189 related articles for article (PubMed ID: 19533372)
1. Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology.
Neumann L; Ritscher A; Müller G; Hafenbradl D
J Comput Aided Mol Des; 2009 Aug; 23(8):501-11. PubMed ID: 19533372
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of fragment screening methods on the p38α kinase: new methods, new insights.
Pollack SJ; Beyer KS; Lock C; Müller I; Sheppard D; Lipkin M; Hardick D; Blurton P; Leonard PM; Hubbard PA; Todd D; Richardson CM; Ahrens T; Baader M; Hafenbradl DO; Hilyard K; Bürli RW
J Comput Aided Mol Des; 2011 Jul; 25(7):677-87. PubMed ID: 21732248
[TBL] [Abstract][Full Text] [Related]
3. The multiple roles of computational chemistry in fragment-based drug design.
Law R; Barker O; Barker JJ; Hesterkamp T; Godemann R; Andersen O; Fryatt T; Courtney S; Hallett D; Whittaker M
J Comput Aided Mol Des; 2009 Aug; 23(8):459-73. PubMed ID: 19533374
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.
Gill AL; Frederickson M; Cleasby A; Woodhead SJ; Carr MG; Woodhead AJ; Walker MT; Congreve MS; Devine LA; Tisi D; O'Reilly M; Seavers LC; Davis DJ; Curry J; Anthony R; Padova A; Murray CW; Carr RA; Jhoti H
J Med Chem; 2005 Jan; 48(2):414-26. PubMed ID: 15658855
[TBL] [Abstract][Full Text] [Related]
6. Design of compound libraries for fragment screening.
Blomberg N; Cosgrove DA; Kenny PW; Kolmodin K
J Comput Aided Mol Des; 2009 Aug; 23(8):513-25. PubMed ID: 19283339
[TBL] [Abstract][Full Text] [Related]
7. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach.
Badrinarayan P; Sastry GN
J Mol Graph Model; 2012 Apr; 34():89-100. PubMed ID: 22306417
[TBL] [Abstract][Full Text] [Related]
9. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
10. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.
van Linden OP; Farenc C; Zoutman WH; Hameetman L; Wijtmans M; Leurs R; Tensen CP; Siegal G; de Esch IJ
Eur J Med Chem; 2012 Jan; 47(1):493-500. PubMed ID: 22137457
[TBL] [Abstract][Full Text] [Related]
11. Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine Kinase.
Smith CR; Dougan DR; Komandla M; Kanouni T; Knight B; Lawson JD; Sabat M; Taylor ER; Vu P; Wyrick C
J Med Chem; 2015 Jul; 58(14):5437-44. PubMed ID: 26087137
[TBL] [Abstract][Full Text] [Related]
12. Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors.
Gozalbes R; Mosulén S; Carbajo RJ; Pineda-Lucena A
J Comput Aided Mol Des; 2009 Aug; 23(8):555-69. PubMed ID: 19421720
[TBL] [Abstract][Full Text] [Related]
13. CellFy: A Cell-Based Fragment Screen against C-Type Lectins.
Schulze J; Baukmann H; Wawrzinek R; Fuchsberger FF; Specker E; Aretz J; Nazaré M; Rademacher C
ACS Chem Biol; 2018 Dec; 13(12):3229-3235. PubMed ID: 30480432
[TBL] [Abstract][Full Text] [Related]
14. The multi-copy simultaneous search methodology: a fundamental tool for structure-based drug design.
Schubert CR; Stultz CM
J Comput Aided Mol Des; 2009 Aug; 23(8):475-89. PubMed ID: 19506805
[TBL] [Abstract][Full Text] [Related]
15. Lessons for fragment library design: analysis of output from multiple screening campaigns.
Chen IJ; Hubbard RE
J Comput Aided Mol Des; 2009 Aug; 23(8):603-20. PubMed ID: 19495994
[TBL] [Abstract][Full Text] [Related]
16. Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide.
Kawatkar S; Wang H; Czerminski R; Joseph-McCarthy D
J Comput Aided Mol Des; 2009 Aug; 23(8):527-39. PubMed ID: 19495993
[TBL] [Abstract][Full Text] [Related]
17. Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase.
Sullivan JE; Holdgate GA; Campbell D; Timms D; Gerhardt S; Breed J; Breeze AL; Bermingham A; Pauptit RA; Norman RA; Embrey KJ; Read J; VanScyoc WS; Ward WH
Biochemistry; 2005 Dec; 44(50):16475-90. PubMed ID: 16342939
[TBL] [Abstract][Full Text] [Related]
18. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
Wassermann AM; Kutchukian PS; Lounkine E; Luethi T; Hamon J; Bocker MT; Malik HA; Cowan-Jacob SW; Glick M
J Med Chem; 2013 Nov; 56(21):8879-91. PubMed ID: 24117015
[TBL] [Abstract][Full Text] [Related]
19. Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation.
Loving K; Salam NK; Sherman W
J Comput Aided Mol Des; 2009 Aug; 23(8):541-54. PubMed ID: 19421721
[TBL] [Abstract][Full Text] [Related]
20. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
Barelier S; Krimm I
Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]